BSE filing, NSE: BAJAJST. Summary written from the filing by ALFA Finder's alert engine.
Bajaj Steel Industries Ltd: key numbers
- Share price
- ₹309.10
- Market cap
- ₹642.9 Cr
- Revenue (annual)
- ₹524.2 Cr
- Net profit (annual)
- ₹36.90 Cr
- P/E (TTM)
- 22.0×Sector 52.8×
- Promoter holding
- 56.62%+0.00% QoQ
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bajaj Steel Industries Ltd
All →Bajaj Steel Industries Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Bajaj Steel Industries Annual General Meeting
Bajaj Steel Industries held its 65th Annual General Meeting on September 23, 2026. Shareholders adopted financial statements, approved a Rs. 1 per share dividend, and re-appointed directors.
Bajaj Steel Industries Annual General Meeting
Bajaj Steel Industries Ltd will hold its 65th Annual General Meeting on September 23, 2026. The meeting will address financial statements, dividends, and director re-appointment.
Bajaj Steel Industries Investor Presentation: Key Takeaways
Q1FY27 revenue grew 11.9% YoY to Rs 120.4 Cr, but margins faced sharp pressure from high raw material costs. Company is diversifying into Infrastructure and Heavy Engineering.
Bajaj Steel Industries Q1 FY27 Results: Net Loss of ₹0.3 Cr
Bajaj Steel Industries Ltd reported revenue from operations of ₹120.4 Cr (+12.0% YoY) and a net loss of ₹0.3 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.3 Cr
Bajaj Steel Industries Board Meeting Date
Bajaj Steel Industries schedules a board meeting for August 08, 2026. The meeting will consider unaudited financial results for the quarter ended June 30, 2026.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.